MYOM1

Across TCGA pan-cancer cohorts, MYOM1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MYOM1 data layer compared with 23 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MYOM1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MYOM1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

OV and HNSC are the cancer types where MYOM1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.687	1.000	.049	4	view →
HNSC	DFS	Tertile	III,IV	1.000	0.911	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MYOM1–OV (DFS)

Open the OV breakdown →